Signios Bio | Advancing Precision Medicine

The Science of Signals, The Promise of Cures

Advancing precision medicine with multiomics
and AI-powered bioinformatics expertise

The latest from Signios

April 10, 2025

Press Release

Signios Bio Launches with AI-Driven Bioinformatics Platform and Multiomics Expertise to Advance Precision Medicine

April 10, 2025

NEWS

Global Health Council recognizes Signios Bio as a Health Hero in docuseries by same name

April 10, 2025

Blog Post

Decoding the Future: Announcing Signios Bio and Entering a New Era of Multiomics and AI-powered Bioinformatics

Diverse, multimodal omics data is the path to make the next breakthroughs in drug discovery & precision medicine

+70%

Multiomics integration increases biomarker discovery success rates by 70%

2.6x

Drug targets with genetic support are 2.6 times more likely to succeed in clinical trials

-25%

Effective use of genomics and bioinformatics in drug development can reduce R&D costs by up to 25%

Leveraging cutting-edge multiomics technologies, advanced bioinformatics, and AI-driven insights, we transform complex biological data into actionable breakthroughs that accelerate drug development, diagnostics, and precision medicine

At Signios, we support genetic research for

Sequencing and multiomics solutions to drive discovery in genetic disease research.

Premade Library Sequencing

RNA Sequencing

Whole Genome Sequencing

Whole Exome Sequencing

Single-cell Sequencing

Spatial Transcriptomics

Immune Repertoire Sequencing

Epigenomics Sequencing

Oncology Panel Sequencing

Long-read Sequencing

Sequencing, multiomics, antibody engineering, and real-world evidence to improve discovery & development.

Identify targets using advanced multiomics technologies and powerful bioinformatics

Accelerate the production of antibodies with our high-throughput antibody engineering lab

Leverage real-world evidence (RWE) from global research networks across the US, Europe, Asia, Africa, Middle East, and Latin America.

Infrastructure and expertise for partners to develop, validate, and distribute Dx and CDx.

Complement your operations with Lab-in-the-cloud (LINC) modular dry-lab services

Leverage our experience & infrastructure for genomic assay development and validation

Bring your testing to our partner and distribution network in 30+ countries globally

Enhanced capabilities with advanced multiomics insights, robust data resources, and streamlined workflows.

Fast & reliable RNA sequencing, whole genome and exome sequencing, long-read sequencing, immune profiling, cancer panel sequencing

Automated, scalable workflows ensuring quick turnaround times and reliable data processing for large volumes of samples

Access to PhD-level scientists and multiomics experts who support everything from study design to data interpretation

Advancing Science in Critical Therapeutic Areas

Oncology

Sequencing capabilities allow for in-depth investigation into tumor genomics, tumor microenvironments, and molecular pathways driving cancer progression

Immunology

Immune profiling of single cells assist in studying immune system dynamics, immune responses, and the mechanisms of immune evasion in cancer

Rare Diseases

Whole genome and exome sequencing to enable discovery of novel genetic mutations and understanding the genetic basis of rare disorders

Neurology Disorders

Spatial biology aids in understanding the molecular underpinnings of neurodegenerative disorders, helping identify biomarkers and potential therapeutic targets

Population Health & Epidemiology

RWE supports epidemiological studies, population health research, and the development of inclusive therapies that address global health disparities

Pharmagenomics & Precision Medicine

Multiomics aids in identifying biomarkers for drug efficacy, safety, and dosage optimization, advancing personalized treatment strategies in various therapeutic areas

Our Customers

Many of the world’s leading academic and biopharmaceutical companies partner with Signios Bio to unlock deeper insights into the biology of disease and enable the future of precision medicine.
Here are just a few.